You may be able to get this leaflet in large print, Braille or as an audio CD, call the RNIB Medicine Leaflet line on 0800 198 5000 for more information.
The product codes for this leaflet are: PL 16950/0057, PL 16950/0058
Phyllocontin® Continus® 225 mg prolonged-release tablets and Phyllocontin® Forte Continus® 350 mg prolonged-release tablets
This medicine is available without prescription. However you still need to take Phyllocontin Continus and Phyllocontin Forte Continus tablets carefully to get the best results from them.
1. What Phyllocontin Continus and Phyllocontin Forte Continus tablets are and what they are used for
2. Before you take Phyllocontin Continus or Phyllocontin Forte Continus tablets
3. How to take Phyllocontin Continus and Phyllocontin Forte Continus tablets
4. Possible side effects
5. How to store Phyllocontin Continus and Phyllocontin Forte Continus tablets
6. Further information
These tablets are used to treat asthma, long-term breathing difficulties such as chronic obstructive pulmonary disease and chronic bronchitis, and are sometimes used to treat heart failure in adults.
They contain the active ingredient aminophylline which belongs to a group of medicines called bronchodilators. Bronchodilators help stop you wheezing and being breathless. Aminophylline also reduces swelling in the lungs of asthma patients and relieves the feeling of ‘tightness’ in their chest.
Before treatment with these tablets tell your doctor or pharmacist if you:
Tell your doctor or pharmacist if you are taking:
Also tell your doctor or pharmacist if:
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. If you take these tablets with some other medicines, the effect of these tablets or the other medicine may be changed.
Alcohol can alter the way these tablets work. Please consult your doctor if you intend to drink alcohol whilst taking these tablets.
If you are pregnant or breastfeeding do not take these tablets until you have talked to your doctor or pharmacist.
Ask your doctor or pharmacist for advice before taking any medicine.
Two different strengths of tablets are available. Your doctor will decide which strength of tablet will suit you best.
Always take these tablets exactly as your doctor or pharmacist has told you.
Swallow your tablets whole with a glass of water. Do not crush or chew them.
Phyllocontin Continus and Phyllocontin Forte Continus tablets are designed to work properly over 12 hours. If a tablet is crushed or chewed the entire 12-hour dose may be absorbed rapidly into your body. This can be dangerous, causing serious problems such as an overdose.
You should take your tablets every 12 hours. For instance, if you take a tablet at 8 o’clock in the morning, you should take your next tablet at 8 o’clock in the evening.
The usual starting dose for adults is one tablet every 12 hours. After a week your doctor may increase your dose to two tablets every 12 hours, depending upon how you respond to treatment. If you are elderly your doctor may suggest a lower dose.
The required dose for children will depend on their weight and the severity of their breathing problems. This should be discussed with your doctor or pharmacist.
Do not exceed the dose recommended by your doctor. You should check with your doctor or pharmacist if you are not sure.
Call your doctor or hospital straight away. People who have taken an overdose may have stomach pains and feel or be sick. They may also have a fast or irregular heartbeat, feel very restless or have a fit. These symptoms may appear up to 12 hours after the overdose. When seeking medical attention make sure that you take this leaflet and any remaining tablets with you to show the doctor.
If you remember within 4 hours of the time your tablet was due, take your tablet straight away. Take your next tablet at your normal time. If you are more than 4 hours late, please call your doctor or pharmacist for advice. Do not take a double dose to make up for a forgotten tablet.
You will probably take these tablets for a long time. Do not stop taking them unless your doctor tells you to, even if you feel better.
If you have any further questions on the use of these tablets, ask your doctor or pharmacist.
Like all medicines, these tablets can cause side effects, although not everybody gets them.
The following side effects have been reported in patients treated with these tablets:
If any of the side effects become serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Keep out of the reach and sight of children.
Do not use any tablets after the expiry date stated on the outer carton and label or blister pack.
EXP 08 2010 means that you should not take the tablets after the last day of that month i.e. August 2010.
Do not store your tablets above 25°C.
Do not take your tablets if they are broken or crushed as this can be dangerous and can lead to serious problems such as overdose.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
The active ingredient is aminophylline hydrate. Each tablet contains 225 mg or 350 mg of aminophylline hydrate.
The other ingredients are:
Phyllocontin Continus tablets are pale yellow, film-coated tablets marked NAPP on one side and SA on the other.
Phyllocontin Forte Continus tablets are pale yellow, film-coated tablets marked NAPP on one side and SA 350 on the other.
In each box there are 56 tablets.
The tablets are made by
for the marketing authorisation holder
This leaflet is also available in large print, Braille or as an audio CD. To request a copy, please call the RNIB Medicine Information line (free of charge) on:
0800 198 5000
You will need to give details of the product name and reference number.
These are as follows:
Product name: Phyllocontin Continus tablets
Reference number: 16950/0057
This leaflet was last approved in 09/2010
® Phyllocontin, Continus, NAPP and the ‘NAPP’ device (logo) are Registered Trade Marks.
© 2008 - 2010 Napp Pharmaceuticals Limited
P0086-A R1V3 UK AW 17-09-10